# Clinical Trial Platform - Development Roadmap

## 🗺️ Strategic Vision

Build a comprehensive, open-source clinical trial platform that supports the entire trial lifecycle from design through regulatory submission.

---

## 📍 Current Position

**You Are Here:** ✅ Phase 1 Complete

```
DESIGN PHASE          EXECUTE PHASE         ANALYZE PHASE
┌──────────────┐    ┌──────────────┐    ┌──────────────┐
│ Sample Size  │    │  Random-     │    │   TLF        │
│ Calculator   │    │  ization     │    │   Generator  │
└──────────────┘    │  Builder     │    └──────────────┘
                    │  ✅ DONE     │         │
                    └──────┬───────┘         │
                           │                 ▼
                    ┌──────┴───────┐    ┌──────────────┐
                    │   IMP        │    │  FDA eCTD    │
                    │   Mgmt       │    │  Export      │
                    └──────────────┘    └──────────────┘
```

---

## 🛣️ Milestone Roadmap

### Milestone 0: Foundation ✅ COMPLETE
**Status:** Production Ready  
**Completion:** April 2025

| Component | Features | Status |
|-----------|----------|--------|
| Cohort Builder | Patient filtering, demographics | ✅ |
| Randomization Builder | Block & stratified, custom ratios | ✅ |
| Trial Simulation | Dose escalation, outcome prediction | ✅ |
| Envelope Generator | Blinded envelopes for sites | ✅ |
| FDA Guidelines | 30+ documents with links | ✅ |
| Playground | Interactive trial builder | ✅ |
| Export System | CSV, Excel, JSON | ✅ |

**Impact:** Fully functional randomization platform

---

### Milestone 1: TLF Generator 🎯 NEXT
**Estimated Effort:** 3-4 sessions (5-6 hours)  
**Priority:** 🔴 CRITICAL

#### What We'll Build
Automated generation of regulatory-ready clinical trial outputs:

**Tables:**
- Table 14.1: Demographics & Baseline Characteristics
- Table 14.2: Efficacy Analysis (Primary Endpoint)
- Table 14.3: Safety Summary (AE by SOC/PT)
- Table 14.4: Disposition & Exposure
- Table 14.5: Medical History & Prior Medications
- Table 14.6: Laboratory Values with Shift Tables

**Listings:**
- Patient demographics (Listing 16.2.1)
- Adverse events by patient (Listing 16.2.7)
- Concomitant medications (Listing 16.2.8)
- Efficacy measurements (Listing 16.2.3)
- Protocol deviations (Listing 16.2.10)

**Figures:**
- Kaplan-Meier survival curves (OS, PFS)
- Forest plots (subgroup analysis)
- Swimmer plots (patient outcomes over time)
- Waterfall plots (tumor response per RECIST)
- Spider plots (individual trajectories)
- Bar charts (response rates with 95% CI)

**Deliverables:**
- Interactive TLF builder UI
- 15+ pre-built table templates
- 10+ figure types
- Patient-level listings
- Export to CSV, Excel, RTF

**Success Criteria:**
- All tables generate without errors
- Figures render correctly
- Export formats work
- CDISC variable naming

---

### Milestone 2: FDA eCTD JSON Export 🎯 FUTURE
**Estimated Effort:** 2-3 sessions (4-5 hours)  
**Priority:** 🔴 HIGH

#### What We'll Build
Structured export package aligned with FDA Data Standards:

**SDTM Datasets:**
- DM (Demographics)
- AE (Adverse Events)
- DS (Disposition)
- EX (Exposure)
- RS (Response - Solid Tumor)
- TU (Tumor Identification)
- TR (Tumor Results)
- LB (Laboratory Tests)
- VS (Vital Signs)
- EG (ECG)

**ADaM Datasets:**
- ADSL (Subject-Level Analysis)
- ADEFF (Efficacy Analysis)
- ADSAFF (Safety Analysis)
- ADTTE (Time-to-Event Analysis)

**Metadata:**
- define.xml generation
- Variable-level metadata
- Code list definitions
- Derivation algorithms
- Computational notes

**Deliverables:**
- One-click SDTM export
- ADaM dataset generation
- define.xml creation
- JSON package for FDA gateway
- Validation checklist

**Success Criteria:**
- Passes FDA Data Standards Validator
- All required domains present
- Proper variable naming
- Metadata complete

---

### Milestone 3: Sample Size Calculator 🎯 FUTURE
**Estimated Effort:** 2-3 sessions (3-4 hours)  
**Priority:** 🟡 HIGH

#### What We'll Build
Statistical planning tool for trial design:

**Phase-Specific:**
- Phase 1: Dose-finding (CRM, 3+3 cohort sizing)
- Phase 2: Single-arm (Simon's 2-stage, ORR-based)
- Phase 2: Randomized (ORR, PFS endpoints)
- Phase 3: Superiority trials
- Phase 3: Non-inferiority trials
- Phase 3: Equivalence trials

**Endpoint-Specific:**
- Binary endpoints (ORR, CR rate, DCR)
- Time-to-event (PFS, OS, DFS - log-rank test)
- Continuous endpoints (biomarker change)

**Advanced Features:**
- Power curves (80%, 85%, 90%, 95%)
- Alpha spending functions (O'Brien-Fleming, Pocock)
- Interim analysis planning (1, 2, or 3 looks)
- Dropout rate adjustment
- Detectable effect size plots
- Sample size vs. power trade-offs

**Deliverables:**
- Interactive calculator UI
- Visual power curves
- Sample size justification text
- Protocol-ready output tables

**Success Criteria:**
- Results match standard software (PASS, nQuery)
- Multiple endpoint support
- Clear visualizations
- Export to protocol text

---

### Milestone 4: IMP Management 🎯 FUTURE
**Estimated Effort:** 2 sessions (3-4 hours)  
**Priority:** 🟡 MEDIUM

#### What We'll Build
Investigational Medicinal Product management system:

**Drug Supply Forecasting:**
- Calculate total units needed per arm
- Account for dropout rates (5%, 10%, 20%)
- Overage calculations (10-30% buffer)
- Depot-level inventory tracking
- Expiry date management with alerts

**Kit Management:**
- Patient kit numbering (IWRS/IRT compatible)
- Blinded kit assignment
- Emergency unblinding codes
- Drug accountability logs

**Label Design:**
- Blinded treatment labels
- Expiry date tracking
- Site-specific labeling
- Multi-language support

**Deliverables:**
- Supply forecasting tool
- Kit numbering generator
- Label template designer
- Inventory tracker

**Success Criteria:**
- Accurate supply calculations
- Compatible with IWRS systems
- Professional label output

---

### Milestone 5: Protocol Builder 🎯 FUTURE
**Estimated Effort:** 2-3 sessions (4-5 hours)  
**Priority:** 🟡 MEDIUM

#### What We'll Build
ICH E6(R3) compliant protocol document generator:

**ICH E6(R3) Sections:**
- Title page & synopsis
- Background & rationale
- Objectives & endpoints wizard
- Inclusion/Exclusion criteria
- Treatment plan
- Schedule of assessments (visit matrix)
- Statistical methods
- Safety monitoring
- Data handling
- References

**Smart Features:**
- Auto-populate from randomization config
- Endpoint selection by cancer type
- Visit schedule with windows
- Sample size justification text
- FDA guideline references

**Deliverables:**
- Interactive protocol editor
- 15+ ICH-compliant sections
- Auto-population from trial config
- Export to Word/PDF

**Success Criteria:**
- ICH E6(R3) structure
- Complete content templates
- Professional formatting
- Export compatibility

---

### Milestone 6: RBM Dashboard 🎯 FUTURE
**Estimated Effort:** 2 sessions (3-4 hours)  
**Priority:** 🟢 LOW

#### What We'll Build
Risk-Based Monitoring dashboard:

**Key Risk Indicators (KRIs):**
- Enrollment rate vs. target
- Screen failure rate
- Protocol deviation rate
- AE reporting rate
- SAE reporting timeliness
- Data query rate
- Missing data percentage
- Outlier detection

**Site Performance:**
- Enrollment by site
- Randomization rate by site
- Data entry lag time
- Query resolution time
- Monitoring visit reports

**Quality Metrics:**
- Central statistical monitoring
- Site risk scoring
- Trigger alerts
- Trend analysis

**Deliverables:**
- KRI dashboard
- Site performance tracker
- Alert system
- Quality metrics

**Success Criteria:**
- Real-time KRI calculation
- Visual dashboards
- Alert generation
- Export to monitoring reports

---

### Milestone 7: Adaptive Designs 🎯 FUTURE
**Estimated Effort:** 3 sessions (5-6 hours)  
**Priority:** 🟢 LOW

#### What We'll Build
Flexible trial designs beyond traditional RCTs:

**Group Sequential Designs:**
- Interim analysis planning
- Alpha spending functions
- Stopping boundaries
- Conditional power

**Adaptive Features:**
- Sample size re-estimation
- Dropping losers
- Adding new arms
- Response-adaptive randomization
- Population enrichment

**Deliverables:**
- Adaptive design configurator
- Boundary visualization
- Conditional power calculator
- Export to statistical analysis plan

---

### Milestone 8: Synthetic Control Arms 🎯 FUTURE
**Estimated Effort:** 2-3 sessions (4-5 hours)  
**Priority:** 🟢 LOW

#### What We'll Build
Use real-world data to augment control arms:

**External Control Construction:**
- Import historical trial data
- Propensity score matching
- Covariate balancing
- Sensitivity analyses

**Hybrid Designs:**
- Single-arm + synthetic control
- Augmented concurrent control
- Bayesian hierarchical models

**Deliverables:**
- External control arm builder
- Propensity score matching
- Covariate balance assessment
- Bayesian borrowing tools

---

### Milestone 9: Patient Recruitment 🎯 FUTURE
**Estimated Effort:** 2 sessions (3-4 hours)  
**Priority:** ⚪ NICE-TO-HAVE

#### What We'll Build
AI-powered enrollment forecasting:

**Enrollment Modeling:**
- Predict time to complete enrollment
- Site-level projections
- Country/region performance
- Seasonal patterns

**Optimization:**
- Optimal site selection
- I/E criteria impact
- Competing trial analysis
- What-if scenarios

**Deliverables:**
- Enrollment predictor
- Site optimizer
- What-if scenario planner
- Recruitment dashboard

---

### Milestone 10: Meta-Analysis 🎯 FUTURE
**Estimated Effort:** 2-3 sessions (4-5 hours)  
**Priority:** ⚪ NICE-TO-HAVE

#### What We'll Build
Cross-study and network meta-analysis:

**Traditional Meta-Analysis:**
- Fixed/random effects models
- Forest plots
- Heterogeneity statistics
- Publication bias

**Network Meta-Analysis:**
- Multi-treatment comparisons
- Indirect comparisons
- Rank probabilities

**Deliverables:**
- Meta-analysis engine
- Forest plot generator
- Network diagram creator
- SUCRA ranking

---

## 📊 Effort Summary

| Milestone | Sessions | Hours | Priority | Cumulative Hours |
|-----------|----------|-------|----------|------------------|
| M0: Foundation | Complete | - | ✅ | ~20 hours |
| M1: TLF Generator | 3-4 | 5-6 | 🔴 | 25-26 hours |
| M2: FDA eCTD Export | 2-3 | 4-5 | 🔴 | 29-31 hours |
| M3: Sample Size | 2-3 | 3-4 | 🟡 | 32-35 hours |
| M4: IMP Mgmt | 2 | 3-4 | 🟡 | 35-39 hours |
| M5: Protocol | 2-3 | 4-5 | 🟡 | 39-44 hours |
| M6: RBM | 2 | 3-4 | 🟢 | 42-48 hours |
| M7: Adaptive | 3 | 5-6 | 🟢 | 47-54 hours |
| M8: Synthetic | 2-3 | 4-5 | 🟢 | 51-59 hours |
| M9: Recruitment | 2 | 3-4 | ⚪ | 54-63 hours |
| M10: Meta-Analysis | 2-3 | 4-5 | ⚪ | 58-68 hours |

---

## 🎯 Next Steps

### Immediate (Next Session)
- [ ] Start Milestone 1: TLF Generator
  - Create table templates
  - Build demographics table (14.1)
  - Add efficacy table (14.2)
  - Implement safety summary (14.3)

### Short-term (Next 2-3 Sessions)
- [ ] Complete TLF Generator
- [ ] Add KM survival curves
- [ ] Implement forest plots
- [ ] Start Milestone 2: FDA eCTD Export

### Medium-term (Next 5-8 Sessions)
- [ ] Complete FDA eCTD Export
- [ ] Build Sample Size Calculator
- [ ] Start IMP Management

### Long-term (10+ Sessions)
- [ ] Complete all Phase 3 modules
- [ ] Begin advanced features
- [ ] Platform integration & testing

---

## 🔗 Dependencies Between Milestones

```
M0 (Foundation) ✅
    │
    ├──▶ M1 (TLF Generator) - Uses randomization & simulation data
    │       │
    │       └──▶ M2 (FDA eCTD Export) - Uses TLF outputs
    │
    ├──▶ M3 (Sample Size Calculator) - Independent
    │
    └──▶ M4 (IMP Management) - Uses randomization arm config
            │
            └──▶ M5 (Protocol Builder) - Uses all previous configs
```

---

**This roadmap provides a strategic view of the platform development journey, with clear milestones and priorities to guide each development session.**
